ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer ...
Upcoming presentations at the ASCO meeting in Chicago highlight potential practice-changing studies in cancer care.
Here is how robotic surgeries are paving way for new gen cancer treatment in the country - Read on to know all about it.
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By ...
Additional Data from ENZAMET Study Show How Decipher Can Help Metastatic Prostate Cancer Patients Avoid Unnecessary Treatment and Enable More Personalized Care The OPTIMA study is a prospective, ...
VCYT jumps 65.8% in a year as Afirma and Decipher volumes surge, guidance lifts, and TrueMRD nears launch with $439M cash and ...
New Jersey hospitals have long been on the cutting edge of medical technology in areas ranging from cancer treatments and cardiovascular ...
Zacks Investment Research on MSN
Here's how much you'd have if you invested $1000 in Veracyte a decade ago
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and ...
A new UCL-led international trial will assess whether AI can perform as well as expert radiologists at detecting prostate ...
For aging men, worrying about prostate health can start to feel like a real … well, you know. But as Dr. Leonard Appleman of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results